Discovering prescription patterns in pediatric acute-onset neuropsychiatric syndrome patients

Arturo Lopez Pineda1, Armin Pourshafeie2, Alexander Ioannidis3

  • 1Department of Biomedical Data Science, Stanford University, CA, USA; Department of Data Science, Amphora Health, Morelia, Mexico.

Insights

A new algorithm identified six distinct treatment patterns for Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). This data-driven approach helps understand how different PANS severities and causes are managed with various medications.

Area of Science:

  • Neuroscience
  • Pediatric Psychiatry
  • Computational Biology

Background:

  • Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) presents abruptly with obsessive-compulsive symptoms and/or eating restrictions, plus cognitive, behavioral, or neurological deficits.
  • Current PANS treatment involves diverse pharmacological, behavioral, and psychotherapeutic interventions, necessitating better understanding of treatment patterns.

Purpose of the Study:

  • To develop a data-driven computational approach for identifying distinct treatment patterns within a PANS patient cohort.
  • To analyze medication prescription histories to reveal underlying clinical practices for managing PANS.

Main Methods:

  • Extraction of medical prescription histories from electronic health records for PANS patients.
  • Development of a modified dynamic programming algorithm for global alignment of medication histories, incorporating time gaps.
  • Clustering of patient medication histories to identify distinct treatment groups.

Main Results:

  • The algorithm identified six distinct clusters representing different medication usage patterns in PANS patients.
  • These clusters correlated with PANS severity and etiology, including high-dose steroids for severe cases, NSAIDs for inflammatory types, and shorter NSAID courses for milder cases.
  • Psychometric scores generally improved within two years across all identified clusters.

Conclusions:

  • The developed algorithm offers a novel way to understand treatment variations in PANS.
  • This approach can aid clinicians in recognizing patient responses to combined drug therapies and tailoring PANS management.
Abstract

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
322
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
110
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
631
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
156
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
109
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
444